These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 30499116)

  • 1. The effect of herpes simplex virus vector-mediated gene therapy of protein phosphatase 1α on bladder overactivity and nociception.
    Majima T; Mori K; Kadekawa K; Takai S; Funahashi Y; Reinhart B; Goins WF; Gotoh M; Glorioso JC; Yoshimura N
    Neurourol Urodyn; 2019 Feb; 38(2):582-590. PubMed ID: 30499116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Herpes Simplex Virus Vector-Mediated Gene Delivery of Poreless TRPV1 Channels Reduces Bladder Overactivity and Nociception in Rats.
    Majima T; Funahashi Y; Takai S; Goins WF; Gotoh M; Tyagi P; Glorioso JC; Yoshimura N
    Hum Gene Ther; 2015 Nov; 26(11):734-42. PubMed ID: 26204493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Herpes simplex virus vector mediated gene therapy of tumor necrosis factor-α blockade for bladder overactivity and nociception in rats.
    Funahashi Y; Oguchi T; Goins WF; Gotoh M; Tyagi P; Goss JR; Glorioso JC; Yoshimura N
    J Urol; 2013 Jan; 189(1):366-73. PubMed ID: 23174234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of herpes simplex virus vector-mediated enkephalin gene therapy on bladder overactivity and nociception.
    Yokoyama H; Oguchi T; Goins WF; Goss JR; Nishizawa O; de Groat WC; Wolfe D; Krisky DM; Glorioso JC; Yoshimura N
    Hum Gene Ther; 2013 Feb; 24(2):170-80. PubMed ID: 23316929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of herpes simplex virus vectors encoding poreless TRPV1 or protein phosphatase 1α in a rat cystitis model induced by hydrogen peroxide.
    Takai S; Majima T; Reinhart B; Goins WF; Funahashi Y; Gotoh M; Tyagi P; Glorioso JC; Yoshimura N
    Gene Ther; 2018 Jan; 25(1):20-26. PubMed ID: 29057994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of herpes simplex virus vector-mediated interleukin-4 gene therapy on bladder overactivity and nociception.
    Oguchi T; Funahashi Y; Yokoyama H; Nishizawa O; Goins WF; Goss JR; Glorioso JC; Yoshimura N
    Gene Ther; 2013 Feb; 20(2):194-200. PubMed ID: 22402319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Herpes simplex virus vector-mediated gene delivery of glutamic acid decarboxylase reduces detrusor overactivity in spinal cord-injured rats.
    Miyazato M; Sugaya K; Goins WF; Wolfe D; Goss JR; Chancellor MB; de Groat WC; Glorioso JC; Yoshimura N
    Gene Ther; 2009 May; 16(5):660-8. PubMed ID: 19225548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphological changes in different populations of bladder afferent neurons detected by herpes simplex virus (HSV) vectors with cell-type-specific promoters in mice with spinal cord injury.
    Shimizu N; Doyal MF; Goins WF; Kadekawa K; Wada N; Kanai AJ; de Groat WC; Hirayama A; Uemura H; Glorioso JC; Yoshimura N
    Neuroscience; 2017 Nov; 364():190-201. PubMed ID: 28942324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Intravesical Liposome-Based Nerve Growth Factor Antisense Therapy on Bladder Overactivity and Nociception in a Rat Model of Cystitis Induced by Hydrogen Peroxide.
    Majima T; Tyagi P; Dogishi K; Kashyap M; Funahashi Y; Gotoh M; Chancellor MB; Yoshimura N
    Hum Gene Ther; 2017 Jul; 28(7):598-609. PubMed ID: 28446032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Herpes simplex virus vector-mediated gene transfer of kynurenine aminotransferase improves detrusor overactivity in spinal cord-injured rats.
    Jia C; Yoshimura N; Liao L
    Gene Ther; 2014 May; 21(5):484-9. PubMed ID: 24598891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene therapy for bladder overactivity and nociception with herpes simplex virus vectors expressing preproenkephalin.
    Yokoyama H; Sasaki K; Franks ME; Goins WF; Goss JR; de Groat WC; Glorioso JC; Chancellor MB; Yoshimura N
    Hum Gene Ther; 2009 Jan; 20(1):63-71. PubMed ID: 20377371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene therapy using replication-defective herpes simplex virus vectors expressing nerve growth factor in a rat model of diabetic cystopathy.
    Sasaki K; Chancellor MB; Goins WF; Phelan MW; Glorioso JC; de Groat WC; Yoshimura N
    Diabetes; 2004 Oct; 53(10):2723-30. PubMed ID: 15448108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene Transfer of Glutamic Acid Decarboxylase 67 by Herpes Simplex Virus Vectors Suppresses Neuropathic Pain Induced by Human Immunodeficiency Virus gp120 Combined with ddC in Rats.
    Kanao M; Kanda H; Huang W; Liu S; Yi H; Candiotti KA; Lubarsky DA; Levitt RC; Hao S
    Anesth Analg; 2015 Jun; 120(6):1394-404. PubMed ID: 25851180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin 10 mediated by herpes simplex virus vectors suppresses neuropathic pain induced by human immunodeficiency virus gp120 in rats.
    Zheng W; Huang W; Liu S; Levitt RC; Candiotti KA; Lubarsky DA; Hao S
    Anesth Analg; 2014 Sep; 119(3):693-701. PubMed ID: 25137003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement in detrusor-sphincter dyssynergia by bladder-wall injection of replication-defective herpes simplex virus vector-mediated gene delivery of kynurenine aminotransferase II in spinal cord injury rats.
    Wang Z; Liao L
    Spinal Cord; 2017 Feb; 55(2):155-161. PubMed ID: 27995942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Herpes simplex virus mediated nerve growth factor expression in bladder and afferent neurons: potential treatment for diabetic bladder dysfunction.
    Goins WF; Yoshimura N; Phelan MW; Yokoyama T; Fraser MO; Ozawa H; Bennett N JR; de Groat WC; Glorioso JC; Chancellor MB
    J Urol; 2001 May; 165(5):1748-54. PubMed ID: 11342969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of urethral wall injection of replication-defective herpes simplex virus-mediated gene transfer of kynurenine aminotransferase on urethral pressure in spinal cord-injured rats.
    Wang Z; Liao L
    Neurourol Urodyn; 2017 Apr; 36(4):1046-1051. PubMed ID: 27391207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of detrusor-sphincter dyssynergia by herpes simplex virus vector mediated gene delivery of glutamic acid decarboxylase in spinal cord injured rats.
    Miyazato M; Sugaya K; Saito S; Chancellor MB; Goins WF; Goss JR; de Groat WC; Glorioso JC; Yoshimura N
    J Urol; 2010 Sep; 184(3):1204-10. PubMed ID: 20663524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved herpes simplex virus type 1 amplicon vectors for proportional coexpression of positron emission tomography marker and therapeutic genes.
    Jacobs AH; Winkeler A; Hartung M; Slack M; Dittmar C; Kummer C; Knoess C; Galldiks N; Vollmar S; Wienhard K; Heiss WD
    Hum Gene Ther; 2003 Feb; 14(3):277-97. PubMed ID: 12639307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Herpes simplex virus vector-mediated delivery of glial cell line-derived neurotrophic factor rescues erectile dysfunction following cavernous nerve injury.
    Kato R; Wolfe D; Coyle CH; Huang S; Wechuck JB; Goins WF; Krisky DM; Tsukamoto T; Nelson JB; Glorioso JC; Chancellor MB; Yoshimura N
    Gene Ther; 2007 Sep; 14(18):1344-52. PubMed ID: 17611585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.